GLP-1 is best known for its incretin effect, whereby it augments glucose-stimulated insulin secretion by pancreatic β cells [14], which has prompted the successful development of GLP-1 based therapies for type 2 diabetes treatment [15]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.